Search

everythinglearnresearchcommunity

for

Search:↓

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Overweight women with PCOS are more likely to have excess male hormones.

Skin changes in women with PCOS are mainly due to hormonal imbalances.

Nonclassic 21-hydroxylase deficiency is a common, treatable genetic disorder causing reversible symptoms like acne and hair loss.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Acne, dermatophytosis, and viral warts are the most common skin problems in a Turkish dermatology clinic.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Doctors should recognize various nail disorders, new allergens, and metabolic syndrome in patients, and use botulinum toxin carefully in aesthetic procedures.

Some antiepileptic drugs can cause weight gain and hair loss, especially in women.

Fluorescence can effectively measure acne treatment progress.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.